Competition

  • April 10, 2025

    Insurance Agency Accuses Former Exec Of Poaching Clients

    A Florida insurance agency has accused its former vice president of sales of poaching clients and misappropriating trade secrets when he left for a direct competitor, according to a lawsuit removed to federal court.

  • April 10, 2025

    1st Circ. Asked To Save $34M Fee Bid In JetBlue-Spirit Case

    Passengers who launched an antitrust challenge to the since-scrapped JetBlue-Spirit Airlines merger have asked the First Circuit to revive their bid to collect up to $34 million in legal fees, insisting that they paved the way for the deal to be blocked, so they should be declared the "prevailing party."

  • April 10, 2025

    Judge DQs Atty Suing FIFA Over Antitrust Allegations

    A Puerto Rican federal judge on Thursday disqualified an attorney suing FIFA and local affiliates over allegedly blocking rival soccer leagues, saying the lawyer cannot simultaneously be a plaintiff, counsel and factual witness.

  • April 10, 2025

    Grayscale Settles Bitcoin Rival's Conn. Biz Interference Suit

    Cryptocurrency firm Osprey Funds LLC and its larger digital asset management rival Grayscale Investments LLC have agreed to settle a lawsuit over the transition of a Grayscale bitcoin investment trust into an exchange-traded fund, or ETF.

  • April 10, 2025

    Pharma Cos.' Patent Practices Limit Drug Access, Report Says

    The two major pharmaceutical companies behind leading GLP-1 products are leveraging so-called patent thickets to maintain their monopolies over the diabetes and weight loss medications, a practice that can impede access to those drugs, according to a report released Thursday.

  • April 10, 2025

    Live Nation Cites Amazon's Win In Urging Nix Of Antitrust Suit

    An attorney for Live Nation Entertainment and Ticketmaster urged a California federal judge Thursday to rethink his tentative opinion to keep alive an antitrust case alleging monopolization of the concert ticketing market, saying the judge did not consider a recent Ninth Circuit decision in favor of Amazon that "maps 100%" to the case.

  • April 10, 2025

    Microsoft Pushes Back On UK's Cloud Software Findings

    Microsoft has responded to the concerns raised by Britain's competition enforcer over the cloud services market, saying that artificial intelligence is radically reshaping the space, and that any regulatory intervention could make the industry less dynamic.

  • April 10, 2025

    Sagitec Sues Deloitte For Defamation In Trade Secrets Spat

    Software company Sagitec Solutions has accused Deloitte Consulting of conducting an "ongoing campaign of disparagement and unfair competition," alleging in a complaint in Delaware federal court that Deloitte has falsely claimed that Sagitec's unemployment and pension administration programs are based on stolen trade secrets.

  • April 10, 2025

    UK Open To SLB-ChampionX Fixes For $8B Oil Services Deal

    The United Kingdom's Competition and Markets Authority expressed openness Thursday to fixes offered to address antitrust concerns over energy-focused global technology company SLB's proposed $7.8 billion acquisition of chemistry solutions provider ChampionX, based in part on a divestiture already inked to address U.S. worries.

  • April 10, 2025

    Sports Promoter Ends US Soccer Antitrust Suit

    The U.S. Soccer Federation and Relevent Sports are nearing the end of a six-year-long antitrust lawsuit in New York federal court, and announced Thursday they reached a settlement agreement resolving a dispute over the sports promotion firm's efforts to host professional international soccer matches in Florida.

  • April 10, 2025

    Meta Trial Rooted In Decade-Old WhatsApp, Instagram Buys

    Federal Trade Commission lawyers are set for a trial Monday that will assess the exact scope of competition that Meta Platform's offerings face providing personal social media services and the reach of monopolization allegations targeting its purchases of WhatsApp and Instagram.

  • April 09, 2025

    OpenAI Countersues Musk For 'Relentless' Harassment

    OpenAI on Wednesday lodged a countersuit to Elon Musk's lawsuit accusing the ChatGPT maker of abandoning its nonprofit mission, urging a California federal court to stop the billionaire from continuing an alleged "harassment campaign" aimed at impeding its success.

  • April 09, 2025

    Trump Orders Agencies To Identify Anticompetitive Rules

    President Donald Trump signed an executive order Wednesday requiring federal agency heads to identify regulations that create anticompetitive barriers with recommendations for what to do about them, following the U.S. Department of Justice's recent announcement of its own similar initiative.

  • April 09, 2025

    Revived Burger King No-Poach Case Survives Dismissal

    A Florida federal judge Wednesday denied Burger King's bid to toss proposed class action claims over the fast-food chain's past use of no-poach provisions in its franchise agreements, finding the workers' antitrust and fraud claims could proceed.

  • April 09, 2025

    Kansas Says Local Gov'ts Usurping State Powers In Shale Case

    Kansas pushed to join multidistrict litigation accusing U.S. shale oil producers of conspiring with OPEC to inflate oil and fuel prices, arguing that local governments don't have the authority to pursue the class claims they've asserted against the companies.

  • April 09, 2025

    Bristol Myers Beats Pomalyst Antitrust Suit Alleging IP Fraud

    A New York federal judge has tossed a proposed antitrust class action accusing Bristol Myers' Celgene subsidiary of fraudulently obtaining patents and filing "sham" infringement lawsuits to block generic versions of its blood-cancer drug Pomalyst, finding that the indirect drug buyer plaintiffs lack standing and haven't plausibly alleged fraud.

  • April 09, 2025

    FDA: Pharmacies' Bid To Keep Making Eli Lilly Drug Is 'Absurd'

    The U.S. Food and Drug Administration said it played by the book when it removed Eli Lilly & Co.'s lucrative weight loss drug from the shortage list and ended compounding pharmacies' right to make the drug, asking a Texas federal judge to grant judgment in the agency's favor.

  • April 09, 2025

    Country's Largest Egg Producer Discloses DOJ Price Probe

    Cal-Maine Foods Inc., which bills itself as the country's largest producer and distributor of fresh shell eggs, on Tuesday became the first company to disclose being targeted by a U.S. Department of Justice civil probe into spiking egg prices.

  • April 09, 2025

    Live Nation Likely Won't Escape Concertgoers' Antitrust Suit

    A California federal court indicated on Wednesday that he's not inclined to toss an antitrust case from consumers accusing Live Nation Entertainment Inc. and Ticketmaster LLC of monopolizing the concert ticketing market following their 2010 merger.

  • April 09, 2025

    2nd Circ. Allows Takeda To Appeal Actos Antitrust Class Cert.

    A split Second Circuit will allow Takeda Pharmaceuticals Co. to immediately appeal a New York federal judge's ruling certifying two classes of direct purchasers and end payors in consolidated antitrust actions accusing the company of unlawfully inflating the price of its diabetes treatment Actos by delaying the entry of generic alternatives.

  • April 09, 2025

    Connell Foley Survives Investment Firm's DQ Bid In Bias Suit

    A federal judge in New Jersey has rejected a Black-owned investment company's request to disqualify a Connell Foley LLP attorney from representing the state in the investment firm's bias case, reasoning that there is nothing showing the law firm or the lawyer previously represented the company.

  • April 09, 2025

    FTC Has Authority To Bring Antitrust Case Against Amazon

    A federal court in Washington found the Federal Trade Commission has the authority to bring an antitrust case targeting Amazon's treatment of sellers on its platform directly in federal court without also pursuing an in-house administrative case.

  • April 09, 2025

    Ancora Drops US Steel Pursuit After Trump Flags Nippon Deal

    Ancora Holdings Group said Wednesday it is withdrawing its slate of director candidates for U.S. Steel's upcoming annual meeting, citing "apparent momentum" for the $14.9 billion acquisition by Japan's Nippon Steel after President Donald Trump announced a fresh national security review of the deal Monday. 

  • April 08, 2025

    Jazz Agrees To Pay $145M To Settle Xyrem Antitrust Fight

    Jazz Pharmaceuticals has agreed to pay $145 million to resolve antitrust litigation accusing it of working with its rival Hikma Pharmaceuticals to stave off generic competitors to Jazz's narcolepsy drug Xyrem, the Ireland-based pharmaceutical company revealed Tuesday.

  • April 08, 2025

    Four Robinhood Users Must Arbitrate Meme Stock Claims

    A Florida federal judge overseeing the multidistrict litigation over Robinhood's decision to freeze trading in certain so-called meme stocks ordered four remaining plaintiffs in the case to arbitrate their claims, writing in an order that there's no dispute a valid arbitration agreement exists.

Expert Analysis

  • Overseas Investment Rule Calls For Compliance Caution

    Author Photo

    Investors should be leery of who and what they are investing in now that the federal outbound investment regime, effective Jan. 2, has extended the governement's regulatory reach to businesses and parties not previously subject to trade restrictions, says Thaddeus McBride at Bass Berry.

  • 5 Factors From Biden's Final Worker Antitrust Guidelines

    Author Photo

    The recent Federal Trade Commission and the U.S. Department of Justice's joint antitrust guidelines for business activities affecting workers cap a flurry of final announcements from the Biden administration, but it's unclear whether the agencies will maintain their support for these measures in the Trump administration, say attorneys at Simpson Thacher.

  • Calif. Cannabis Decision Deepens Commerce Clause Divide

    Author Photo

    In Peridot Tree v. Sacramento, the Eastern District of California joined a growing minority of courts that have found the dormant commerce clause inapplicable to state-regulated marijuana, and the Ninth Circuit will soon provide important guidance on this issue, say attorneys at Perkins Coie.

  • 4 Employment Law Areas Set To Change Under Trump

    Author Photo

    President Donald Trump's second term is expected to bring significant changes to the U.S. employment law landscape, including the potential for updated worker classification regulations, and challenges to diversity, equity and inclusion that are already taking shape, say attorneys at Debevoise.

  • Recent Suits Show Antitrust Agencies' Focus On HSR Review

    Author Photo

    The U.S. Department of Justice's suit this month against KKR for inaccurate and incomplete premerger filings, along with other recent cases, highlights the agency's increasing scrutiny of Hart-Scott-Rodino Act compliance for private equity firms, say attorneys at Willkie.

  • Private-Bidding Compliance Lessons From Siemens Plea Deal

    Author Photo

    Siemens Energy’s recent wire fraud conspiracy guilty plea shows that U.S. prosecutors are willing and able to police the private, domestic bidding market to protect the integrity of the competitive marketplace, and companies will need a robust compliance program to mitigate these risks, say attorneys at Foley Hoag.

  • FTC Report On AI Sector Illuminates Future Enforcement

    Author Photo

    The Federal Trade Commission's report on cloud service providers and their partnerships with developers of artificial intelligence's large language models suggests that the agency will move to rein in Big Tech with antitrust enforcement to protect startups, say attorneys at Squire Patton.

  • Mentorship Resolutions For The New Year

    Author Photo

    Attorneys tend to focus on personal achievements or career milestones when they set yearly goals, but one important area often gets overlooked in this process — mentoring relationships, which are some of the most effective tools for professional growth, say Kelly Galligan at Rutan & Tucker and Andra Greene at Phillips ADR.

  • Algorithm Price-Fixing Ruling May Lower Antitrust Claims Bar

    Author Photo

    A Washington federal court's refusal to dismiss Duffy v. Yardi Systems, an antitrust case over rent prices allegedly inflated by revenue management software, creates an apparent split in the lower courts over how to assess such claims, say attorneys at Morgan Lewis.

  • Series

    Coaching Little League Makes Me A Better Lawyer

    Author Photo

    While coaching poorly played Little League Baseball early in the morning doesn't sound like a good time, I love it — and the experience has taught me valuable lessons about imperfection, compassion and acceptance that have helped me grow as a person and as a lawyer, says Alex Barnett at DiCello Levitt.

  • 5 Litigation Funding Trends To Note In 2025

    Author Photo

    Lawyers and their clients must be prepared to navigate an evolving litigation funding market in 2025, made more complicated by a new administration and the increasing overall cost of litigation, says Jeffery Lula at GLS Capital.

  • How FTC Sent A $5.6M Warning Against Jumping The Gun

    Author Photo

    The Federal Trade Commission's recent record $5.6 million "gun jumping" action against Verdun Oil, for allegedly exerting control over EP Energy before the mandatory waiting period under U.S. antitrust law expired, warns companies that they must continue to operate independently during review, say attorneys at Ballard Spahr.

  • Predicting Where State AGs Will Direct Their Attention In 2025

    Author Photo

    In 2025, we expect state attorneys general will navigate a new presidential administration while continuing to further regulate and police financial services, artificial intelligence, junk fees and antitrust, say attorneys at Troutman Pepper.

  • A Look At FDA's Plans To Establish New OTC Drug Category

    Author Photo

    The U.S. Food and Drug Administration's recently finalized rule, creating a new over-the-counter pathway for drugs when patients satisfy certain conditions, may be useful for off-patent drugs with established safety records, though switching to OTC comes with additional costs and considerations, say attorneys at Skadden.

  • Chancery May Have Raised Bar For Books, Records Requests

    Author Photo

    The Delaware Court of Chancery recently approved the denial of a books and records demand against Amazon, raising important questions about what evidence and purpose a stockholder is required to show to succeed on such a request, say attorneys at Selendy Gay.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Competition archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!